Cytokine gene expression in human LPS- and IFNγ-stimulated mononuclear cells is inhibited by heparin

Thrombosis and Haemostasis

Volumn 79, Issue 5, 1998, Pages 959-962

  Attanasio, Monica ^a   Gori, Anna Maria ^a   Giusti, Betti ^a   Pepe, Guglielmina ^a,b   Comeglio, Paolo ^a   Brunelli, Tamara ^a   Prisco, Domenico ^a   Abbate, Rosanna ^a   Gensini, Gian Franco ^a   Neri Serneri, Gian Gastone ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; MONONUCLEAR CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 18844473425     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615102     Document Type: Article

References (35)

1. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 1990; 59: 783-836.
2. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlation and interactions in the production of interleukin-6, IL-1 and TNF in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75: 40-7.
3. Muller JM, Ziegler-Heitbrock HWL, Baeuerle PA. Nuclear factor kappa B, a mediator of Lipopolysaccharide effects. Immunobiol 1993; 187: 233-56.
4. Blajchman MA, Young E. Ofosu FA. Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits. Ann N Y Acad Sci 1989; 556: 245-54.
5. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625-6.
6. Castellot JJ Jr, Favreau LV, Karnovsky MJ, Rosemberg RD. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin: possible role of a platelet endoglycosidase. J Biol Chem 1982; 257: 11256-60.
7. Folkman J. Regulation of angiogenesis; a new function of heparin. Biochem Pharmacol 1985; 34: 905-9.
8. Vannucchi S, Pasquali F, Porciatti F, Chiarugi V, Magnelli L, Bianchini P. Binding, internalization and degradation of heparin and heparin fragments by cultured endotelial cells. Thromb Res 1988; 49: 373-83.
9. Glimelius B, Busch C, Hook M. Binding of heparin on the surface of cultured human endothelial cells. Thromb Res 1978; 12(5): 773-82.
10. Leung L, Saigo K, Grant D. Heparin binds to human monocytes and modulates their pro-coagulant activities and secretory phenotypes. Effect of histidine-rich glycoprotein. Blood 1989; 73: 177-82.
11. Oh TH, Naidoo SS, Jaques LB. The uptake and disposition of S35 heparin by macrophages in vitro. J Reticuloendothel 1973, 13: 134-42
12. Gallagher JT, Lyon M. Degradation of internalized proteoglycan. In: Heparin, chemical and biological properties, clinical applications. Lane DA, Lindahl U, eds. London: Arnold 1989; pp 142-3.
13. Au YPT, Kenagy RD, Clowes AW. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J Biol Chem 1992; 267: 3438-44.
14. Au YPT, Montgomery KF, Clowes AW. Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circulation Res 1992; 70: 1062-9.
15. Wright TC Jr, Pukac LA, Castellot JJ Jr, Karnovsky MJ, Levine RA, KimPark HY, Campisi J. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA 1989, 86: 3199-203.
16. Rogers C, Welt FGP, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996; 16: 1312-8.
17. Pepe G, Giusti B, Attanasio M, Gori AM, Comeglio P, Martini F, Gensini GF, Abbate R, Neri Serneri GG. Tissue Factor and Plasminogen Activator Inhibitor Type 2 expression in human stimulated monocytes is inhibited by heparin. Semin Thromb Hemost 1997; 23: 135-41.
18. Hogasen AKM, Abrahamsen TG. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines. but simultaneously stimulates C3 production. Thromb Res 1995; 80: 179-84.
19. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; 5: 9-15.
20. Bevilacqua MP, Amrani D, Mosesson MW, Bianco C. Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med 1981; 153: 42-60.
21. Chomczynski P, Sacchi N. Single-slep-method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
22. Feinberg AP, Volgestein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-11.
23. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11: 571-611.
24. Frieri M, Metcalfe DD. Analysis of the effect of mast cell granules on lymphocyte blastogenesis in the absence and presence of mitogens: Identification of heparin as a granule-associated suppressor factor. J Immunol 1983; 131: 1942-7.
25. Currie GA. Effect of heparin on mixed lymphocytes cultures. Nature (Lond.)1967; 215: 164-9.
26. Ramsden L, Rider C. Selective and differential binding of interleukin (IL)-1a, IL-1b, IL-2 and IL-6 to glycosaminoglycans. Eur J Immunol 1992; 22: 3027-31.
27. Nelson DS. Reaction to antigens in vivo of the peritoneal macrophages of guinea pigs with delayed-type hypersensitivity. Lancet 1963; ii: 175-80.
28. Cohen F, Benacerraf B, McCluskey RT, Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol 1967; 98: 351-7.
29. Tangelder GJ, Arfors K-E. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides. Blood 1991; 77 (7): 1565-71.
30. Matzner Y, Marx G, Drexler R, Eldor A. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost 1984; 52: 134-7.
31. Nelson MR, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccarides bind L- and P-selectin and inhibit acute inflammation. Blood 1993; 82 (11): 3253-8.
32. Zhang Z, Fuentes NL, Fuller GM. Characterization of the IL 6 responsive elements in the γ fibrinogen gene promoter. J Biol Chem 1995; 270: 24287-91.
33. Engelberg H. Low-dose intermittent heparin therapy decreases plasma fibrinogen levels. Semin Thromb Hemost 1991; 17 Suppl 2: 219-23.
34. Salvioni A, Marenzi GC, Agostoni P, Grazi S, Guazzi MD. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase. Eur Heart J 1994; 15 (5): 654-9.
35. Stouthard J M L, Levi M, Hack E, Veenhof C H N, Romijn HA, Sauerwein HP, van der Poll T. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76 (5): 738-42.